Browsing by Author "Ingonga, Johnstone"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Evaluation of the Adjuvanticity of Artemisinin with Soluble Leishmania Major Antigens in BALB/C Mice
    (Elsevier, 2009) Karanja, Muhia Robert; Ngure, Peter Kamau; Ingonga, Johnstone; Gicheru, Michael M.; Kepha, Stella; Njeru, Laban Ireri; Wachira, Dorcas; Mwangi, Milkah; Nyamwamu, Lydia B.; Kimutai, Albert; Tonui, Willy K.
    Objective; To determine the adjuvant potential of artemisinin with a soluble leishmanial antigen in vaccinating BALB/c mice. Methods; Seventy two female BALB/c mice were randomly assigned into six groups. The mice were vaccinated with soluble leishmania antigens (SLA) alone, artemisinin co-administered with SLA, SLA and Bacille Calmette Guérin (BCG) vaccine, and artemisinin and BCG alone. Unvaccinated mice formed the control group. The induction of cell-mediated immunity following vaccination was determined by measuring in vitro lymphocyte proliferation and the production of interleukin (IL)-4, IL-5 and gamma interferon (IFN-γ) determined by flow cytometry. Protection against L. major was determined by quantifying parasite burdens in L. major infected footpads using a limiting dilution assay and by measuring lesion sizes of the infected footpad compared to the contralateral uninfected footpad. Results; Mice receiving SLA plus artemisinin produced significantly high levels of IL-4 and IL-5 (P < 0.05) and low levels of IFN-γ, resulting in exacerbated disease. In addition, subcutaneous administration of SLA + artemisinin, artemisinin alone or SLA alone resulted in the development of large footpad swellings and high parasite loads that were comparable to those of the control unvaccinated mice (P > 0.05), resulting in exacerbated disease. Conclusion; These data suggest that artemisinin is not a suitable adjuvant for Leishmania vaccines. However, since artemisinin has been shown to be effective against Leishmania parasites in vitro and in vivo, further studies ought to be conducted to determine its immunochemotherapeutic potential when co-administered with Leishmania antigens.
  • Thumbnail Image
    Item
    Immunization with a combination of Leishmania major lipophosphoglycan (LPG) and Phlebotomus duboscqi salivary gland lysates (SGLs) abrogates protective efect of LPG against L. major in BALB/c mice
    (African Journal of Health Sciences, 2011) Robert Karanja; Ingonga, Johnstone; Mwangi, Milkah; Mwala, Dennis; Lugalia, Reuben; Magambo, Japhet; Tonui, , Willy K.
    The use of vector-derived antigens has become widely acknowledged as a possible answer to vaccination against vector borne diseases. Sand fly saliva is one such vector-derivative that has been targeted for vaccine development, either alone or in combination with other antigens. Previous studies have suggested a synergistic protective effect accruing from a parasite-derived and vector-derived cocktail vaccine. This study sought to evaluate such a synergistic effect in a cocktail vaccine comprising Phlebotomus duboscqi salivary gland lysates (SGLs) mixed with L. major lipophosphoglycan (LPG). Mice were immunized subcutaneously with SGLs, LPG or a cocktail of the two. The immunizations were then boosted twice every 2 weeks, followed by a challenge with 105 L. major metacyclic promastigotes 2 weeks after the last boost. Lesion growth was monitored over 35 days using vernier calipers, and footpad parasitaemia determined by simple limiting dilution assay. Immunizations with LPG alone gave effective protection against L. major infection (P < 0.05) compared to controls, whereas SGLs, and the LPG + SGLs cocktail failed to protect. This study did not demonstrate a protective synergistic effect accruing from LPG + SGLs cocktail vaccine, and suggests a need to evaluate the effects of saliva in vaccinations with other Leishmanial antigens.